Synonyms: ACP-044 | ACP044 | compound 1 [WO2020159643A1] [1]
Compound class:
Synthetic organic
Comment: The chemical structure for ebaresdax is claimed in Cersci Therapeutics' patent WO2020159643A1 [1], which allowed us to associate this structure with their clinical lead candidate ACP-044. This was confirmed by synonym matches on PubChem. Ebaresdax (ACP-044) is a first-in-class, orally administered, non-opioid analgesic that was developed for potential to treat neuropathic, surgical and osteoarthritic pain.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(4R)-2-(2-hydroxyanilino)-5,5-dimethyl-4H-1,3-thiazole-4-carboxylic acid |
International Nonproprietary Names ![]() |
|
INN number | INN |
11566 | ebaresdax |
Synonyms ![]() |
|
ACP-044 | ACP044 | compound 1 [WO2020159643A1] [1] |
Database Links ![]() |
|
CAS Registry No. | 1334471-39-4 (source: WHO INN record) |
GtoPdb PubChem SID | 472319271 |
PubChem CID | 53362112 |
Search Google for chemical match using the InChIKey | OASISJWJIHWVKX-SECBINFHSA-N |
Search Google for chemicals with the same backbone | OASISJWJIHWVKX |
Search PubMed clinical trials | ebaresdax |
Search PubMed titles | ebaresdax |
Search PubMed titles/abstracts | ebaresdax |
UniChem Compound Search for chemical match using the InChIKey | OASISJWJIHWVKX-SECBINFHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | OASISJWJIHWVKX-SECBINFHSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Ebaresdax (links to external site)
Cat. No. HY-139569 |